| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 19, 2011New Access for Aortic Valve Replacement Achieves High Procedural Success in Italian Study of High Risk Patients
PARIS, May 19, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today issued a statement on results of clinical data presented at EuroPCR 2011 that show the Medtronic CoreValve(R) System,...
-
May 18, 2011Clinical Data from Multiple Studies Presented at EuroPCR Show Next-Generation Device Delivers Excellent Safety and Efficacy in Challenging Patient Population
PARIS, May 18, 2011 (BUSINESS WIRE) -- For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent (DES) from...
-
May 17, 2011Two-year Results from Europe and Canada Represent Longest-term Quality-of-life Assessment of All Transcatheter Aortic Valves to Date
PARIS, May 17, 2011 (BUSINESS WIRE) -- New clinical data presented today at EuroPCR 2011 demonstrate immediate and long-term health-related quality-of-life (HRQoL) benefits for patients receiving...
-
May 16, 2011EuroPCR Program Includes Endovascular Late-Breakers on IN.PACT Drug-Eluting Balloons and Mo.Ma Ultra Embolic Protection System Enrollment in IN.PACT SFA I DEB Study Completed; PIs for IN.PACT SFA II Study Selected
MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. (NYSE: MDT) today announced...
-
May 16, 2011Kyphon(R) Xpede(TM) Bone Cement Is the Latest Offering from Medtronic for Treatment of Spinal Fractures
MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. launch of Kyphon Xpede Bone Cement, a quick-to-dough polymethylmethacrylate (PMMA) bone cement for...
-
May 13, 2011
MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year end 2011 on Tuesday, May 24, 2011....
-
May 13, 2011Kyphon(R) Balloon Kyphoplasty is Among Treatments that Continue to be Covered by Major Medicare Administrative Contractor
MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that Noridian Administrative Services, a major Medicare Administrative Contractor providing Medicare...
-
May 12, 2011Highlights Include Late-Breakers and Other Scientific Sessions on CoreValve System, Resolute Drug-Eluting Stent, IN.PACT Drug-Eluting Balloons, Mo.Ma Embolic Protection System, and Renal Denervation with Symplicity Catheter System
MINNEAPOLIS, May 12, 2011 (BUSINESS WIRE) -- New clinical data on a range of innovative medical devices from Medtronic, Inc. (NYSE: MDT), to treat cardiac and vascular diseases - from severe...
-
May 10, 2011
MINNEAPOLIS, May 11, 2011 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) announced today that its board of directors named Omar Ishrak as the company's new chairman and chief executive officer,...
-
May 9, 2011
MINNEAPOLIS & TARRYTOWN, N.Y., May 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and Bayer HealthCare have expanded their international alliance to now include the United States and will...